Full FDA Approval of Travere’s Kidney Drug Stiffens Competition With Novartis, Calliditas
A Travere Therapeutics drug for a rare disease that can progress to kidney failure has converted its status to full...
Calliditas
A Travere Therapeutics drug for a rare disease that can progress to kidney failure has converted its status to full...
